These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 8912403)

  • 1. The 5-HT1A antagonist, WAY 100635, ameliorates the cognitive impairment induced by fornix transection in the marmoset.
    Harder JA; Maclean CJ; Alder JT; Francis PT; Ridley RM
    Psychopharmacology (Berl); 1996 Oct; 127(3):245-54. PubMed ID: 8912403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of 5-HT(1A) receptors in the dorsal raphe ameliorates the impairment of spatial learning caused by intrahippocampal 7-chloro-kynurenic acid in naive and pretrained rats.
    Carli M; Balducci C; Samanin R
    Psychopharmacology (Berl); 2001 Oct; 158(1):39-47. PubMed ID: 11685382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 5-HT1A antagonist, WAY 100 635, alleviates cognitive impairments induced by dizocilpine (MK-801) in monkeys.
    Harder JA; Ridley RM
    Neuropharmacology; 2000 Feb; 39(4):547-52. PubMed ID: 10728875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain.
    Corradetti R; Laaris N; Hanoun N; Laporte AM; Le Poul E; Hamon M; Lanfumey L
    Br J Pharmacol; 1998 Feb; 123(3):449-62. PubMed ID: 9504386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the role of 5-HT1A receptors in spatial and aversive learning in the rat.
    Lüttgen M; Elvander E; Madjid N; Ogren SO
    Neuropharmacology; 2005 May; 48(6):830-52. PubMed ID: 15829255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective 5-HT1A antagonists WAY 100635 and NAD-299 attenuate the impairment of passive avoidance caused by scopolamine in the rat.
    Misane I; Ogren SO
    Neuropsychopharmacology; 2003 Feb; 28(2):253-64. PubMed ID: 12589378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties.
    Schechter LE; Smith DL; Rosenzweig-Lipson S; Sukoff SJ; Dawson LA; Marquis K; Jones D; Piesla M; Andree T; Nawoschik S; Harder JA; Womack MD; Buccafusco J; Terry AV; Hoebel B; Rada P; Kelly M; Abou-Gharbia M; Barrett JE; Childers W
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1274-89. PubMed ID: 15951399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cocaine increases serotonergic activity in the hippocampus and nucleus accumbens in vivo: 5-HT1a-receptor antagonism blocks behavioral but potentiates serotonergic activation.
    Müller CP; Carey RJ; De Souza Silva MA; Jocham G; Huston JP
    Synapse; 2002 Aug; 45(2):67-77. PubMed ID: 12112399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin 5-HT receptor blockade enhances Ca(2+)/calmodulin-dependent protein kinase II function and membrane expression of AMPA receptor subunits in the rat hippocampus: implications for memory formation.
    Schiapparelli L; Del Río J; Frechilla D
    J Neurochem; 2005 Aug; 94(4):884-95. PubMed ID: 16092936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonist-induced increase in 5-HT1A-receptor expression in adult rat hippocampus and cortex.
    Abbas SY; Nogueira MI; Azmitia EC
    Synapse; 2007 Jul; 61(7):531-9. PubMed ID: 17447257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MP-3022, a new putative antagonist at pre- and postsynaptic 5-HT1A receptors.
    Przegaliński E; Filip M; Bijak M; Wedzony K; Budziszewska B; Tokarski K; Maćkowiak M; Fijał K
    Pol J Pharmacol; 1996; 48(1):13-22. PubMed ID: 9112623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT1A receptors in the dorsal hippocampus mediate the anxiogenic effect induced by the stimulation of 5-HT neurons in the median raphe nucleus.
    Dos Santos L; de Andrade TG; Zangrossi Junior H
    Eur Neuropsychopharmacol; 2008 Apr; 18(4):286-94. PubMed ID: 17728111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposing effects of AMPA and 5-HT1A receptor blockade on passive avoidance and object recognition performance: correlation with AMPA receptor subunit expression in rat hippocampus.
    Schiapparelli L; Simón AM; Del Río J; Frechilla D
    Neuropharmacology; 2006 Jun; 50(7):897-907. PubMed ID: 16620883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535.
    Lejeune F; Millan MJ
    Synapse; 1998 Oct; 30(2):172-80. PubMed ID: 9723787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5HT antagonists attenuate MK801-impaired radial arm maze performance in rats.
    Boast C; Bartolomeo AC; Morris H; Moyer JA
    Neurobiol Learn Mem; 1999 May; 71(3):259-71. PubMed ID: 10196105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the selective 5-HT1A receptor antagonist WAY 100635 on the inhibition of e.p.s.ps produced by 5-HT in the CA1 region of rat hippocampal slices.
    Pugliese AM; Passani MB; Corradetti R
    Br J Pharmacol; 1998 May; 124(1):93-100. PubMed ID: 9630348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors.
    Hagiwara H; Fujita Y; Ishima T; Kunitachi S; Shirayama Y; Iyo M; Hashimoto K
    Eur Neuropsychopharmacol; 2008 Jun; 18(6):448-54. PubMed ID: 18164909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WAY 100635, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by blockade of hippocampal NMDA receptors.
    Carli M; Silva S; Balducci C; Samanin R
    Neuropharmacology; 1999 Aug; 38(8):1165-73. PubMed ID: 10462129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlating efficacy in rodent cognition models with in vivo 5-hydroxytryptamine1a receptor occupancy by a novel antagonist, (R)-N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405).
    Hirst WD; Andree TH; Aschmies S; Childers WE; Comery TA; Dawson LA; Day M; Feingold IB; Grauer SM; Harrison BL; Hughes ZA; Kao J; Kelly MG; van der Lee H; Rosenzweig-Lipson S; Saab AL; Smith DL; Sullivan K; Rizzo SJ; Tio C; Zhang MY; Schechter LE
    J Pharmacol Exp Ther; 2008 Apr; 325(1):134-45. PubMed ID: 18182558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short and efficient syntheses of analogues of WAY-100635: new and potent 5-HT1A receptor antagonists.
    Marchais S; Nowicki B; Wikström H; Brennum LT; Halldin C; Pike VW
    Bioorg Med Chem; 2001 Mar; 9(3):695-702. PubMed ID: 11310604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.